Gordon Cameron Obe

Biography

Gordon joined Quotient in 2013, having served as CFO of its previous owners, Quotient Bioresearch group, for six years. Gordon is responsible for all financial matters, including financial reporting, liaising with Quotient’s investors and lenders and leading fund-raisings and M&A activities. Gordon has over 20 years’ experience in the pharmaceutical and biotech industry, in both private equity-backed and public companies. He spent 11 years as CFO and then CEO of Acambis plc, a FTSE-350 vaccines development company. He headed up Acambis’ U.S. operations for five years, delivering a $500 smallpox vaccine counter-bioterrorism contract for the U.S. Government. Prior to that Gordon spent six years as an investment banker, primarily with N M Rothschild, where he advised clients on a variety of corporate finance transactions. He qualified as a Chartered Accountant with Ernst & Young. In 2004, Gordon was awarded the Officer of the Order of the British Empire for services to the British biotechnology industry in the U.S.

Research Interest

Biochemistry, Pharmacy, Biotechnology, Clinical Research